10/31/2024 4:52 PM | BIOTECHNOLOGY VALUE FUND II LP (Reporting) BIOTECHNOLOGY VALUE FUND L P (Reporting) Biotechnology Value Trading Fund OS LP (Reporting) BVF GP HOLDINGS LLC (Reporting) BVF I GP LLC (Reporting) BVF II GP LLC (Reporting) BVF INC/IL (Reporting) BVF PARTNERS L P/IL (Reporting) BVF Partners OS Ltd. (Reporting) Eledon Pharmaceuticals, Inc. (Issuer) Eledon Pharmaceuticals (Issuer) LAMPERT MARK N (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/31/2024 4:49 PM | BIOTECHNOLOGY VALUE FUND L P (Filed by) Eledon Pharmaceuticals, Inc. (Subject) Eledon Pharmaceuticals (Subject)
| Form SC 13G/A | |
10/31/2024 4:50 PM | BIOTECHNOLOGY VALUE FUND L P (Filed by) Eledon Pharmaceuticals, Inc. (Subject) Eledon Pharmaceuticals (Subject)
| Form SC 13G/A | |
10/30/2024 5:36 AM | Eledon Pharmaceuticals, Inc. (Filer) Eledon Pharmaceuticals (Filer)
| Form 424B5 | |
10/30/2024 5:24 AM | Eledon Pharmaceuticals, Inc. (Filer) Eledon Pharmaceuticals (Filer)
| Form 424B5 | |
10/29/2024 8:27 PM | Eledon Pharmaceuticals, Inc. (Filer) Eledon Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/29/2024 7:00 AM | Eledon Pharmaceuticals, Inc. (Filer) Eledon Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
|
10/02/2024 11:15 PM | Eledon Pharmaceuticals, Inc. (Filer) Eledon Pharmaceuticals (Filer)
| Form EFFECT | |
09/20/2024 4:00 PM | Eledon Pharmaceuticals, Inc. (Filer) Eledon Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/20/2024 3:16 PM | Eledon Pharmaceuticals, Inc. (Filer) Eledon Pharmaceuticals (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |
08/19/2024 3:33 PM | Eledon Pharmaceuticals, Inc. (Filer) Eledon Pharmaceuticals (Filer)
| Form 10-Q/A | |
08/19/2024 3:36 PM | Eledon Pharmaceuticals, Inc. (Filer) Eledon Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/19/2024 3:30 PM | Eledon Pharmaceuticals, Inc. (Filer) Eledon Pharmaceuticals (Filer)
| Form 10-K/A | |
08/14/2024 4:12 PM | Eledon Pharmaceuticals, Inc. (Filer) Eledon Pharmaceuticals (Filer)
| Form NT 10-Q | |
08/14/2024 4:15 PM | Eledon Pharmaceuticals, Inc. (Filer) Eledon Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/12/2024 3:30 PM | Eledon Pharmaceuticals, Inc. (Filer) Eledon Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/10/2024 3:47 PM | Eledon Pharmaceuticals, Inc. (Filer) Eledon Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/10/2024 3:41 PM | Eledon Pharmaceuticals, Inc. (Filer) Eledon Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/05/2024 11:15 PM | Eledon Pharmaceuticals, Inc. (Filer) Eledon Pharmaceuticals (Filer)
| Form EFFECT | |
05/24/2024 3:02 PM | Eledon Pharmaceuticals, Inc. (Filer) Eledon Pharmaceuticals (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |
05/22/2024 6:36 PM | Eledon Pharmaceuticals, Inc. (Filer) Eledon Pharmaceuticals (Filer)
| Form D Notice of Exempt Offering of Securities | |
05/15/2024 6:00 AM | Eledon Pharmaceuticals, Inc. (Filer) Eledon Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
05/13/2024 4:04 PM | BIOTECHNOLOGY VALUE FUND II LP (Reporting) BIOTECHNOLOGY VALUE FUND L P (Reporting) Biotechnology Value Trading Fund OS LP (Reporting) BVF GP HOLDINGS LLC (Reporting) BVF I GP LLC (Reporting) BVF II GP LLC (Reporting) BVF INC/IL (Reporting) BVF PARTNERS L P/IL (Reporting) BVF Partners OS Ltd. (Reporting) Eledon Pharmaceuticals, Inc. (Issuer) Eledon Pharmaceuticals (Issuer) LAMPERT MARK N (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/07/2024 6:15 AM | Eledon Pharmaceuticals, Inc. (Filer) Eledon Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/28/2024 3:30 PM | Eledon Pharmaceuticals, Inc. (Filer) Eledon Pharmaceuticals (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
03/28/2024 3:01 PM | Eledon Pharmaceuticals, Inc. (Filer) Eledon Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/14/2024 2:35 PM | ARMISTICE CAPITAL, LLC (Filed by) Eledon Pharmaceuticals, Inc. (Subject) Eledon Pharmaceuticals (Subject)
| Form SC 13G | |
11/09/2023 4:00 PM | Eledon Pharmaceuticals, Inc. (Filer) Eledon Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |